Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats
Rolando Hernández-Muñoz
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Search for more papers by this authorMauricio Díaz-Muñoz
Centro de Neurobiología, Campus UNAM-Juriquilla, Querétaro, Qro., Mexico
Search for more papers by this authorJuan A. Suárez-Cuenca
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Search for more papers by this authorCristina Trejo-Solís
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Search for more papers by this authorVerónica López
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Search for more papers by this authorLourdes Sánchez-Sevilla
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Search for more papers by this authorLucía Yáñez
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Search for more papers by this authorCorresponding Author
Victoria Chagoya De Sánchez Ph.D.
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Victoria Chagoya de Sánchez, PhD., Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM), Apdo, Postal 70-243, México 04510, D. F., Mexico. fax: (525) 622-5611===Search for more papers by this authorRolando Hernández-Muñoz
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Search for more papers by this authorMauricio Díaz-Muñoz
Centro de Neurobiología, Campus UNAM-Juriquilla, Querétaro, Qro., Mexico
Search for more papers by this authorJuan A. Suárez-Cuenca
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Search for more papers by this authorCristina Trejo-Solís
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Search for more papers by this authorVerónica López
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Search for more papers by this authorLourdes Sánchez-Sevilla
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Search for more papers by this authorLucía Yáñez
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Search for more papers by this authorCorresponding Author
Victoria Chagoya De Sánchez Ph.D.
Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM). México 04510, D.F., Mexico
Victoria Chagoya de Sánchez, PhD., Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM), Apdo, Postal 70-243, México 04510, D. F., Mexico. fax: (525) 622-5611===Search for more papers by this authorAbstract
Cirrhosis is one of the most common causes of mortality worldwide, because hepatic dysfunction constitutes a potentially lethal condition. Having demonstrated the hepatoprotective effect of adenosine against CCl4-induced cirrhosis, the present study was aimed at assessing adenosine's effect on an already-established micronodular cirrhosis. Chronic administration of CCl4 (10 weeks) induced a cirrhotic state, characterized by increased liver fibronectin and collagen types I and III content, enhanced expression of α-1 (I) collagen mRNA, portal hypertension, and liver dysfunction. After CCl4 discontinuation (5 weeks), increased persitance of α-1 (I) collagen mRNA expression and deposition, enhanced proline incorporation into collagen and prolyl hydroxylase activity evidenced active fibrogenesis. Several weeks after CCl4 withdrawal, deposited collagen showed an enhanced type I/III ratio, which was associated with deficient collagenolytic activity in cirrhotic livers. Liver expression of some metalloproteinases (MMPs) and of tissue inhibitors of MMPs (TIMPs) also indicated decreased collagen breakdown in cirrhotic livers. Parameters indicative of oxidative stress (mainly protein oxidation) were persistently augmented. These events were coincident with diminished regenerative capacity of the cirrhotic liver. Intraperitoneal adenosine administration to CCl4-induced cirrhotic rats blocked active fibrogenesis and increased the collagen degradation (most probably by decreasing liver TIMPs levels), normalizing collagen-type ratios. In addition, the nucleoside promoted an effective hepatocyte's proliferation in the cirrhotic liver and accelerated normalization of parameters indicative of liver function and oxidative stress. Thus, adenosine readily reversed an experimental cirrhosis through stimulating liver collagenolytic and proliferative capacities, as well as by accelerating functional recovery.
References
- 1 Bruck R, Hershkoviz R, Lider O, Aeed H, Zaidel L, Matas Z, Barg J, et al. Inhibition of experimentally-induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-Gly-Asp epitope. J Hepatol 1996; 24: 731–738.MEDLINE
- 2 Clement B, Grimaud J-A, Campion JP, Deugnier Y, Guillouzo A. Cell types involved collagen and fibronectin production in normal and fibrotic human liver. Hepatology 1986; 6: 225–234.MEDLINE
- 3 Galligani L, Lonati-Galligani M, Fuller GC. Collagen synthesis in explant cultures of normal and CCl4-treated mouse liver. Toxicol Appl Pharmacol 1979; 48: 131–137.MEDLINE
- 4 Bickel M, Baringhaus K-H, Gerl M, Gunzler V, Kanta J, Schmidts I, Stapf M, et al. Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4-hydroxylase inhibitor. Hepatology 1998; 28: 404–411.MEDLINE
- 5 Abdel-Aziz G, Lebeau G, Bescan PY, Clément B, Campion JP, Guillouzo A. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol 1990; 137: 1333–1342.MEDLINE
- 6 Manna Z, Guopei S, Minuk GY. Effects of hepatic stimulator substance, herbal medicine, seleniun/vitamin E, and ciprofloxacin on cirrhosis in the rat. Gastroenterology 1996; 110: 1150–1155.MEDLINE
- 7 Matsuda Y, Matsumoto K, Ichida T, Nakamura T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 1995; 118: 643–649.MEDLINE
- 8 Pérez-Tamayo R. Is cirrhosis of the liver experimentally produced by CCl4 an adequate model of human cirrhosis? Hepatology 1983; 3: 112–120.MEDLINE
- 9 Callea F, Brisigotti M, Fabbretti G, Sciot R, Van Eyken P, Favret M. Cirrhosis of the liver. A regenerative process. Dig Dis Sci 1991; 36: 1287–1293.MEDLINE
- 10 Kokudo N, Kothary PC, Eckhauser FE, Raper E. Transforming growth factor-α (TGF-α) improves hepatic DNA synthesis after hepatectomy in cirrhotic rats. J Surg Res 1992; 52: 648–655.MEDLINE
- 11 Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996; 24: 636–642.MEDLINE
- 12 Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5: 226–230.MEDLINE
- 13 Hernández-Muñoz R, Díaz-Muñoz M, Suárez J, Chagoya de Sánchez V. Adenosine partially prevents cirrhosis induced by carbon tetrachloride in rats. Hepatology 1990; 12: 242–248.MEDLINE
- 14 Hernández-Muñoz R, Díaz-Muñoz M, Chagoya de Sánchez V. Effects of adenosine administration on the function and membrane composition of liver mitochondria in carbon tetrachloride-induced cirrhosis. Arch Biochem Biophys 1992; 294: 160–167.MEDLINE
- 15 Hernández-Muñoz R, Díaz-Muñoz M, Chagoya de Sánchez V. Possible role of cell of cell redox state on collagen metabolism in carbon tetrachloride-induced cirrhosis as evidenced by adenosine administration to rats. Biochim Biophys Acta 1994; 1200: 93–99.MEDLINE
- 16 Hernández-Muñoz R, Díaz-Muñoz M, López V, López-Barrera F, Yáñez L, Vidrio S, Aranda-Fraustro A, et al. Balance between oxidative damage and proliferative potential in an experimental rat model of CCl4-induced cirrhosis: protective role of adenosine administration. Hepatology 1997; 26: 1100–1110.MEDLINE
- 17 Hutterer F, Eisenstadt M, Rubin E. Turnover of hepatic collagen in reversible and irreversible fibrosis. Experientia 1970; 26: 244–245.MEDLINE
- 18 Rojkind M, González E. An improved method for determining specific radioactivities of proline-14C and hydroxyproline-14C in collagen and noncollagenous proteins. Anal Biochem 1974; 57: 1–7.MEDLINE
- 19 Aguilar-Delfín I, López-Barrera F, Hernández-Muñoz R. Selective enhancement in lipid peroxidation in plasma membrane in two experimental models of liver regeneration: partial hepatectomy and acute CCl4 administration. Hepatology 1996; 24: 657–662.MEDLINE
- 20 Camps J, Bargallo T, Giménez A, Alie S, Caballería J, Parés A, Joven J, et al. Relationship between hepatic lipid peroxidation and fibrogenesis in carbon tetrachloride-treated rats: effect of zinc administration. Clin Sci 1992; 83: 695–700.MEDLINE
- 21 Sauer H, Willmanns W: Thymidine kinase. In: HU Bergmeyer, J Bergmeyer, eds. Methods of Enzymatic Analysis. Deerfield Beach, FL: Verlag Chemie, 1983: 468–473.
- 22 Hernández-Muñoz R, Glender W, Díaz-Muñoz M, García-Sáinz JA, Chagoya de Sánchez V. Effects of adenosine on liver cells damage induced by carbon tetrachloride. Biochem Pharmacol 1984; 33: 2599–2604.MEDLINE
- 23 Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464–478.MEDLINE
- 24 Lowry HO, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275.
- 25 Martin PY, Xu DL, Niederberger M, Weigert A, Tsai P, St. John J, Gines P, et al. Upregulation of the endothelial constitutive NOS: a major role of increased NO production in cirrhotic rats. Am J Physiol 1996: 270: F494–F499.MEDLINE
- 26 Ehrinpreis MN, Giambrome MA, Rojkind M. Liver proline oxidase activity and collagen synthesis in rats with cirrhosis induced by carbon tetrachloride. Biochim Biophys Acta 1980; 629: 184–193.MEDLINE
- 27 Pérez-Tamayo R, Montfort I, González E. Collagenolytic activity in experimental cirrhosis of the liver. Exp Mol Pathol 1987; 47: 300–308.MEDLINE
- 28 Chomczynski P, Saachi N. Single step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–159.MEDLINE
- 29 Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels of TGF-β1, fibronectin, and collagen. Am J Physiol 1992; 262: H1860–H1866.
- 30 Masseroli M, Caballero T, O'Valle F, Del Moral RM, Pérez-Milena A, Del Moral RG. Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis. J Hepatol 2000; 32: 453–464.MEDLINE
- 31 Martínez-Hernández A. The hepatic extracellular matrix. II. Electron immunohistochemical studies in rats with CCl4-induced cirrhosis. Lab Invest 1985; 53: 166–186.MEDLINE
- 32 Fischer-Nielsen A, Poulsen HE, Hansen BA, Hage E, Keiding S. CCl4 cirrhosis in rats: irreversible histological changes and differentiated functional impairment. J Hepatol 1991; 12: 110–117.MEDLINE
- 33 Chagoya de Sánchez V, Díaz-Muñoz M, Hernández-Muñoz R. Reversion of experimental cirrhosis induced by carbon tetrachloride by adenosine administration. Hepatology 1998; 28: 641A.
- 34 Mezey E. Prevention of alcohol-induced hepatic fibrosis by phosphatidylcholine. Gastroenterology 1994; 106: 257–259.MEDLINE
- 35 Masuda H, Fukumoto M, Hirayoshi K, Nagata K. Coexpression of the collagen-binding stress protein HSP47 gene and the 1(I) and 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1994; 94: 2481–2488.MEDLINE
- 36 Risteli J, Tuderman L, Kivirikko KY. Intracellular enzymes of collagen biosynthesis in rat liver as a function of age in hepatic injury induced by dimethylnitrosamine. Biochem J 1976; 158: 369–376.MEDLINE
- 37 Tanner MS, Jackson D, Mowat AP. Hepatic collagen synthesis in a rat model of cirrhosis, and its modification by colchicine. J Pathol 1981; 135: 179–187.MEDLINE
- 38 Panduro A, Shalaby F, Biempica L, Shafritz DA. Changes in albumin, α-fetoprotein and collagen gene transcription in CCl4-induced hepatic fibrosis. Hepatology 1988; 8: 259–266.MEDLINE
- 39 Seyer JM. Interstitial collagen polymorphism in rat liver with CCl4-induced cirrhosis. Biochim Biophys Acta 1980; 629: 490–498.MEDLINE
- 40 Rojkind M, Giambrone MA, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979; 76: 710–719.MEDLINE
- 41 Rojkind M, Kershenobich D. Effect of colchicine on collagen, albumin and transferring synthesis by cirrhotic rat liver slices. Biochim Biophys Acta 1975; 378: 415–423.MEDLINE
- 42 Arthur MJP. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol 2000; 279: G245–G249.
- 43 Van Wart HE, Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A 1990; 87: 5578–5582.MEDLINE
- 44 Arthur MJP, Friedman SL, Roll FJ, Bissell DM. Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J Clin Invest 1989; 84: 1076–1085.MEDLINE
- 45 Takahara T, Furui K, Yata Y, Jin B, Zhang LP, Nambu S, Sato H, et al. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers. Hepatology 1997; 26: 1521–1529.MEDLINE
- 46 Takahara T, Furui K, Funaki J, Nakayama Y, Itoh H, Miyabayashi C, Sato H, et al. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology 1995; 21: 787–795.MEDLINE
- 47 Iredale JP. Tissue inhibitor of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol 1997; 29: 43–54.MEDLINE
- 48 Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cells apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538–549.MEDLINE
- 49 Koda M, Murawaki Y, Hirayama C. Free and small peptide-bound [14C] hydroxyproline synthesis in rat liver in vitro in CCl4-induced hepatic fibrosis. Biochem Biophys Res Commun 1988; 151: 1128–1135.MEDLINE
- 50 Sanz N, Díez-Fernández C, Fernández-Simóne L, Alvarez A, Cascales M. Relationship between antioxidant systems, intracellular thiols and DNA ploidy in liver of rats during experimental cirrhogenesis. Carcinogenesis 1995; 16: 1585–1593.MEDLINE
- 51 Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Shuppan D. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 1997; 26: 643–649.MEDLINE
- 52 Chojkier M, Brenner DA. Therapeutic strategies for hepatic fibrosis. Hepatology 1988; 8: 176–182.MEDLINE
- 53 Baraona E, Behrens U, Ma XL, Hernández-Muñoz R, Uppal R, Lieber CS. Contribution of exogenous ethanol and endogenous substrates to acetaldehyde-adduct formation in liver injury. Alcohol Alcohol 1991:Suppl 1: 249–254.
- 54 Haney A, Peacock EE, Madden J. Liver regeneration and hepatic collagen deposition in rats with dimethylnitrosamine-induced cirrhosis. Ann Surg 1972; 175: 863–869.MEDLINE
- 55 Kohno A, Mizumoto R, Honjo Y. Changes after major resection of experimental cirrhotic liver. Am J Surg 1977; 134: 248–252.MEDLINE
- 56 Fouad FM, Mamer OA, Shahidi F. Acute-phase response in rat to carbon tetrachloride-azathioprine induced cirrhosis and partial hepatectomy of cirrhotic liver. J Toxicol Environ Health 1996; 47: 601–615.MEDLINE